About NeuroQore
NeuroQore is a company based in Ottawa (Canada) founded in 2012. It operates as a HealthTech. NeuroQore has raised $1.76 million across 2 funding rounds from investors including IndieBio. NeuroQore offers products and services including Neuromodulation Treatment. NeuroQore operates in a competitive market with competitors including Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and Neuroprex, among others.
- Headquarter Ottawa, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.76 M (USD)
in 2 rounds
-
Latest Funding Round
$1.51 M (USD), Series A
Jul 14, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroQore
NeuroQore offers a comprehensive portfolio of products and services, including Neuromodulation Treatment.
Innovative neuromodulation treatments for neurobehavioral conditions are developed.
Funding Insights of NeuroQore
NeuroQore has successfully raised a total of $1.76M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.51 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuroQore
NeuroQore has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked |
Investor details for NeuroQore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroQore
Investment portfolio details for NeuroQore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroQore
Detailed financials for NeuroQore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuroqore Comparisons
Peer comparison for NeuroQore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroQore
NeuroQore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and Neuroprex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a wearable device for stress and anxiety management
|
|
| Locked | Locked | Locked |
Non-invasive TMS therapy is provided for major depressive disorder treatment.
|
|
| Locked | Locked | Locked |
Neurotechnology solutions for EEG, TMS, and tDCS are developed.
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation devices for mood disorders are manufactured.
|
|
| Locked | Locked | Locked |
Wearable devices are developed to modulate tissues for neurological diseases.
|
Detailed competitors of NeuroQore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuroqore
Complete news archive for NeuroQore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroQore
NeuroQore was founded in 2012 and raised its 1st funding round 4 years after it was founded.
NeuroQore is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
NeuroQore is a funded company, having raised a total of $1.76M across 2 funding rounds to date.
NeuroQore is engaged in the development of pioneering neuromodulation treatments targeting various neurobehavioral conditions, with a primary focus on major depressive disorder and suicidality. Collaboration with world-class universities and research clinics is maintained to explore transformative solutions. The healthcare gap in effective interventions for treatment-resistant depression and acute suicidality is addressed through innovative approaches. Efforts are directed towards creating impactful solutions for devastating disorders affecting millions globally.
NeuroQore's top competitors include NeuroStar, Flow Neuroscience and Magstim.
NeuroQore offers Neuromodulation Treatment.
NeuroQore has 1 investor. Key investors include IndieBio.